Saint-Luc University Hospital

Brussels 1200

1 studies enrolling now · 8 studies all time

What they study most

Bladder Cancer, Breast Cancer, Cachexia; Cancer, Candidemia, Candidiasis, Invasive, Cervix Cancer, Endometrium Cancer, Esophagus Cancer, Fungal Infection, Invasive Candidiases, Lung Cancer(NSCLC), Metastatic Castration-resistant Prostate Cancer

Studies at this site

• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection — Recruiting now
• Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation — Stopped early
• Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole — Stopped early
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis — Completed
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed